HDAC8 serves as a mediator in the promotion of myocardial hypertrophy and fibrosis by modulating gene expression and MAPK and Akt signalling pathways, presenting itself as a potential therapeutic target for addressing myocardial hypertrophy. This evidence concerns the gene AKT1 and cardiac hypertrophy.